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Abstract
Introduction: The aim of this study was to determine 8-OHdG concentration as a biomarker of oxidant-induced DNA dam-
age and to assess total antioxidant status (TAS) in gingival and peripheral blood during periodontal lesion.
Materials and Methods: The study included 56 untreated periodontitis patients (26 with aggressive periodontitis, and 30 with
chronic periodontitis (CP). The control group consisted of 25 healthy volunteers without pathological changes in the peri-
odontium. Competitive ELISA was used to measure 8-OHdG. A colorimetric method based on the reduction of ABTSo+
radical cation generation was used to measure TAS. 
Results: Significantly higher 8-OHdG concentrations were detected in the gingival blood in both groups of patients with peri-
odontitis than in the control group. Subjects with CP had significantly decreased TAS levels in the gingival blood compared
with the control group. A significantly decreased TAS level in the peripheral blood in both patient groups compared with the
control group was found. Significant positive correlation between TAS levels in venous and gingival blood in all the peri-
odontitis patients and in the CP group was observed.
Conclusions: The oxidative burst in periodontitis may lead to significant local damage to nucleic acids. The significantly
decreased TAS level in the gingival blood of CP patients compared with the healthy subjects suggests the possibility of a sig-
nificant decrease in local antioxidant system capacity during the course of periodontitis. The decreased TAS level in the
peripheral blood in the group of all patients with periodontitis may be one of the pathogenic mechanisms underlying the links
between periodontal disease and several systemic diseases for which periodontitis is regarded as a independent risk factor. 
Key words: reactive oxygen species, 8-hydroxy-2’-deoxyguanosine, total antioxidant status, oxidative stress, periodontitis.
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INTRODUCTION
Reactive oxygen species (ROS) encompass a variety
of partially reduced metabolites of oxygen. They are
generated through a variety of processes, e.g. ionizing
radiation, ultrasound, UV radiation, respiratory protein
oxidation, activation of the mitochondrial respiratory
chain, and from peroxisomes and enzymatic reactions.
They are also produced in a “respiratory burst” from
phagocytes. They act in phagosomes as agents toxic to
microorganisms, fungi, parasites, and neoplasmic cells
and are thus a decisive factor in phagocytes’ intracellu-
lar killing mechanism [11, 36]. While most ROS have
extremely short half-lives, they can cause substantial
damage to tissue and cellular components, e.g. cellular
phospholipids, nucleic acids, proteins, carbohydrates,
and enzymes. Lipid peroxidation is initiated by the
hydroxyl radical, which affects polyunsaturated fatty
acids or membrane phospholipids [35]. Lipid hydroper-
oxides and aldehydes are formed in this way; as second
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physical properties of cellular membrane are modified
and the mitochondrial respiratory chain activity is
decreased. The hydroxyl radical, in cooperation with
metal ions bound to the DNA chain, reacts directly with
nucleic acids, causing DNA damage and cracking, which
may have mutagenic consequences [6, 10, 14]. Another
effect of excess ROS on DNA is the activation of specif-
ic metabolic systems, e.g. calcium-dependent endonu-
cleases, which split the DNA chain. Damaged DNA
becomes more immunogenic, causing autoantibody pro-
duction. Studies on hypoxanthine/xanthine oxidase-
-dependent damage to DNA structure in the presence
of calcium ions identified products which may be used as
oxidative DNA damage markers. These are 5,6-dihydro-
cytozine,4,6-diamino-5-formamidopirymidine,2,6-
-diamino-4-hydoxy-5-form-amidopirymidine, 8-hydro-
xyadenine, 8-hydroxyguanine, and 8-hydroxy-2’-deoxy-
guanosine [5, 34].
Both non-radical and radical species have been
demonstrated to be capable of degrading in vivo proteo-
glycans, which are the main components of the basic
substance of connective tissue. Hyaluronic acid depoly-
merization caused by ROS may be characterized by gly-
coside bond fragmentation between monomers
(between glucuronic acid and acetylglucosamine) [10,
36]. Many other extracellular matrix components (colla-
gen, fibronectin, laminin) have been found to be
degraded to low-molecular-weight peptides.
For homeostasis, extra- and intra-cellular preventive
mechanisms must exist. This function is played by antiox-
idants, which may be regarded as those substances which,
when present at low concentrations compared with those
of an oxidizable substrate, will significantly delay or inhib-
it oxidation of that substrate [4, 6, 7, 11, 36]. 
Oxidative stress is defined as an imbalance between
oxidant and antioxidant protection. It is an important
etiopathogenic factor in over 50 general diseases [5],
including atherosclerosis [19] with its complications and
diabetes mellitus [15, 27], for which, in turn, periodonti-
tis is a risk factor. In this context it is interesting to assess
the parameters connected with oxidative stress in peri-
odontitis. In addition, there are few published data on
the roles of free radicals and antioxidants in the patho-
genesis of periodontal diseases. 
The aim of this study was to determine 8-hydroxy-2’-
-deoxyguanosine (8-OHdG) concentrations and total
antioxidant status (TAS) in peripheral and gingival
blood serum of periodontitis patients. The relationships
between these markers of oxidative stress and total
antioxidant capacity and clinical parameters of peri-
odontitis were examined.
MATERIALS AND METHODS
The study included 56 periodontitis patients, 33
females and 23 males, aged 18–55 years (mean: 39.7
years). All patients signed informed consent forms prior
to enrollment in the study. Approval for the study was
obtained from the Ethics Committee of Wroc³aw
Medical University. The patients were enrolled in the
study according to the following criteria: absence of sys-
temic disease, lack of any sign of infection, and no use of
systemic medications which could affect immuno-inflam-
matory reactions, microflora, or oxidative stress (espe-
cially the intake of vitamins A, C, and E). Medical histo-
ries were assessed to exclude patients with conditions in
which oxidative stress played an important role. The exis-
tence of such disease (even in the past) disqualified such
patients. Smokers were also excluded from this study.
Aggressive periodontitis (AgP) [23] was diagnosed
in patients with rapid attachment loss (generalized
GAP: periodontal pocket depth (PD) >5 mm around at
least three teeth other than the first molars and incisors,
localized: PD >5 mm around two teeth, one of which is
a first molar, and involving no more than two teeth
other than the first molar and incisors), rapid bone
destruction (>50% bone loss at diseased sites), lack of
or a weak relationship between dental plaque and the
severity of gingival inflammation, and familial aggrega-
tion. Chronic periodontitis (CP) [25] was diagnosed in
patients with at least 10 sites with PD >5 mm, evidence
of bone loss of more than 1/3 of the root length on the
last tooth per quadrant, an association between the
extent of gingival inflammation and dental plaque, and
association with a local predisposing factor (e.g. subgin-
gival calculus or iatrogenic factors).
The following patients were included in the study: 26
subjects, 18 females and 8 males aged 18–45 years
(mean: 31.5 years), with AgP and 30 subjects, 15 females
and 15 males aged 35–55 years (mean: 44.9 years) with
CP. The control group consisted of 25 healthy volun-
teers, 15 females and 10 males aged 22–50 years (mean:
33.2 years), in good general health without any signs of
gingival inflammation or periodontal destruction. The
periodontal status of the subjects was determined by
measuring the plaque index (PI) [31], approximalraum
plaque index [24], papillary bleeding index (PBI) [29],
and the modified sulcular bleeding index [1] and by
recording PD. The clinical parameters are presented in
Table 1. All of the clinical examinations were performed
by one examiner, a periodontist who was not blinded, in
the periodontology department.
Blood samples were taken in the morning between
8:00–9:30, the subjects having had no food or drink. The
samples (5 ml) were taken from the cubical vein and gin-
gival blood (100 µl) was aspirated during PBI measure-
ment by gentle puncture of the gingival papilla at the
sites of the most severe inflammation. Gingival blood
was collected into heparinized glass microcapillary tubes
(the same as for hematocrit test) using an Eppendorf
pipette and centrifuged immediately. Peripheral blood
samples were clotted for 30 min and centrifuged at
1000×g for 10 min. The serum samples were stored at
–80°C until assayed.
8-OHdG levels were measured in duplicate by
a competitive ELISA kit (OXIS, Portland, OR, USA)
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tivity of the method was 1 ng/ml. Intra- and inter-assay
coefficients of variation for the procedure were 9.2 and
10.8%, respectively.
TAS was evaluated with a kit supplied by Randox
Laboratories Ltd. using a colorimetric method based on
the reduction of ABTS radical cation generation
(ABTSo+ 2,2-azinobis-3-ethylbenzthiazoline sulfonate
cation) by antioxidants in the serum samples. The
antioxidative potential was examined by spectrophoto-
metric evaluation of the intensity of staining after the
addition of ABTSo+ cation radical from the patients’
sera. TAS in the peripheral and gingival blood was pre-
sented in mmol/l as an equivalent of Trolox (vitamin
E analog). The calculation was performed relative to the




where ∆A=A2–A1, A1 being the initial absorbance and
A2 the absorbance after exactly 3 min of reaction. F was
used to calculate TAS:
TAS=F×[∆A(blank)–∆A(sample)]
The intra- and inter-assay coefficients of variation
were 3.7 and 4.2%, respectively. 
Each variable was tested by the Shapiro-Wilk test and
Levene’s test for homogeneity of variances. Student’s
t-test was used for a normal distribution and homogenous
variances and Mann-Whitney’s test for a non-normal dis-
tribution and/or non-homogenous variances. The level of
significance was α=0.05. To detect a relationship
between two variables, Spearman’s correlation test was
conducted. The level of significance was α=0.01.
RESULTS
An increased mean concentration of 8-OHdG was
observed in the gingival blood of both patient groups
compared with the control group. Asignificant difference
in this marker’s concentration between patients with AgP
and CP was noted (p=0.019). No statistically significant
difference was observed in 8-OHdG concentration in
venous blood between the examined groups (Table 2).
Subjects with CP had a significantly decreased TAS
level in gingival blood compared with the control group
of healthy patients. Significantly decreased TAS level in
the peripheral blood in the group of all patients com-
pared with the control group was found. There was also
a significant difference in TAS level between patients
with different forms of periodontitis (p=0.001; Table 3).
Correlation analysis in all the subjects revealed
a positive correlation between TAS level in gingival
blood and TAS level in venous blood (p<0.001,
R=0.37). A significant positive correlation was also
found between TAS levels in venous and in gingival
blood in the group of all periodontitis patients
(p=0.001, R=0.43) and in those with CP (p=0.009,
R=0.49). Gingival and peripheral levels of 8-0HdG and
TAS did not show any significant correlation with the
clinical parameters of either patient group (p>0.01).
DISCUSSION 
Numerous studies have evaluated the use of gingival
crevicular fluid (GCF) [3, 4, 9, 12, 13, 18, 35] and saliva
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Table 1. Clinical parameters in experimental groups and controls 
Parameter  All diseased patients  AgP  GAP  CP  Control 
(n=56) (n=26) (n=20) (n=30)  (n=25) 
PI 0.96±0.71 0.91±1.12 1.03±0.87 1.10±0.58 0.18±0.311
API 75.2±21.3 69.2±33.7 79.3±23.5 75.3±19.8 20.3±20.52
PBI 2.07±0.97 2.11±1.45 2.49±0.97 1.87±0.86 0.27±0.223
mSBI 76.6±23.0 73.5±35.7 84.4±20.6 75.5±21.6 15.1±10.14
PD 4.17±1.02 4.28±1.51 4.65±0.96 4.02±0.84 1.94±0.215
1 Differences between all periodontitis group and controls are p<0.001; 2 differences between all periodontitis group and controls
are p<0.001; 3 differences between all periodontitis group and controls are p<0.001; 4 differences between all periodontitis group
and controls are p<0.001; 5 differences between all periodontitis group and controls are p<0.001.
PI – plaque index, API – approximalraum plaque index, PBI – papillary bleeding index, mSBI – modified sulcular bleeding index,
PD – periodontal pocket depth, GAP – generalized agressive periodontitis.
Table 2. The concentration of 8-OHdG in venous and gingi-
val blood
Examined 8-OHdG level 8-OHdG level
group in venous blood  in gingival blood 
(ng/ml) (ng/ml)
All diseased patients  10.66±4.39 17.40±7.101
(n=56)
AgP (n=26) 11.61±3.95 20.36±8.442
CP (n=30) 9.75±4.78 14.52±4.493, 4
Control (n=25)  11.44±8.61 10.71±4.35
1 p=0.000 compared with the control group; 2 p=0.000 com-
pared with the control group; 3 p=0.001 compared with the
control group; 4 p=0.019 significant difference between AgP
and CP.
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oxidative stress markers and antioxidants during peri-
odontitis. In this investigation, gingival blood was used
to achieve this aim. Levels of comparison of soluble
adhesion molecules from gingival and peripheral blood
during periodontitis were investigated by Krugluger et
al. [22]. Concentrations of oxidative stress biomarkers in
gingival blood should correlate to different stages of the
local inflammation better than those in peripheral blood
serum. The findings of the present study indicate signif-
icant differences in the activity of an oxidative stress
marker and the antioxidant capacity in gingival and
peripheral blood during AgP and CP. Sampling of the
GCF demands the use of expensive Periotron® 8000 to
measure fluid volume. Besides that it is not clear if all
the chemical compound is eluted from the paper strips.
In the opinion of the present authors, sampling of the
gingival blood is only minimally invasive and this biolog-
ical fluid can be used to examine local etiopathogenic
mechanisms in periodontitis.
8-OHdG is currently used as a recognized biomark-
er of oxidant-induced DNA damage. Increased levels of
circulating 8-OHdG have been detected in neoplasms,
various forms of neurodegenerative diseases, rheuma-
toid arthritis, diabetes mellitus, chronic renal failure,
and recombinant human erythropoietin resistance in
hemodialysis patients [2, 15, 20]. In the accessible liter-
ature, only two studies were found in which 8-OHdG
concentration was determined in periodontitis patients,
but in mixed saliva [33, 34].
The mean concentrations of 8-OHdG in the gingival
blood in both groups of periodontits patients were sta-
tistically higher than in the control group. The aggres-
sive form of periodontitis was typified by the highest
concentration of this nucleoside and it was significantly
higher than in the CP patient group. Takane et al. [33,
34] reported significantly higher levels of 8-OHdG in
the saliva of periodontitis patients than in a control
group. On this basis it may be concluded that the oxida-
tive burst in periodontitis is so extensive that it leads to
significant local DNA damage. Especially extensive oxi-
dant-induced DNA damage exists in the most aggressive
forms of periodontitis. In the present study, no signifi-
cant correlation between 8-OHdG concentrations in
gingival blood and clinical data was found. Takane et al.
[34] also found a lack of significant correlation between
8-OHdG levels in whole saliva and clinical parameters
(bleeding on probing, pocket depth, and clinical attach-
ment level). It was explained that this biomarker is influ-
enced by present disease activity and not by the level of
advancement of disease in the past. Furthermore, other
data showed that measurement of salivary 8-OHdG
level may prove useful in identifying patients with peri-
odontally involved teeth of hopeless prognosis [33].
Significantly decreased TAS levels in the gingival
blood of CP patients compared with the control group
were found. This result is in broad agreement with other
studies on the local (GCF and saliva) activity of antioxi-
dants in patients with periodontitis. Indeed, Guarnieri
et al. [18] showed no differences in superoxide anion
scavenging in GCF examination of CP patients and
a control group. Chapple et al. [13] evaluated total
antioxidant capacity of GCF in a chemiluminescence
assay with luminol and with the use of Trolox. In the
periodontitis patient group the characteristics of antiox-
idant protection indicated the possibility of decreased
local TAS. In the same study the authors detected sig-
nificantly decreased antioxidant capacity in stimulated
mixed saliva of these patients. Kohen et al. [21] also con-
firmed, by a cyclic voltammetric assay, reduced activity
of low-molecular-weight antioxidants in saliva.
Concentrations of glutathione in GCF and TAS in the
plasma or GCF of patients with CP were significantly
lower than in controls [12]. Total antioxidant capacity of
GCF and plasma from patients with CP was significant-
ly lower than in healthy control samples [9].
Furthermore, Mashayekhi et al. [26] reported that the
decrease in saliva antioxidant concentration in peri-
odontitis subjects is associated with disease severity.
Studies based on the currently accepted methodolo-
gy indicate that in periodontitis patients (especially in
CP) there may be a significantly decreased local capaci-
ty of antioxidant mechanisms. This is accompanied by
increased ROS activity [6, 36] resulting from activated
neutrophils and macrophages in the active phases of dis-
ease. The whole mouth, not only the periodontium, may
be under the influence of these implications. 
In the present study, positive correlation was shown
between TAS level in gingival and peripheral blood of
all patients and in the CP group. The absence of such
a dependence in the control group with a healthy peri-
odontium may indicate a connection between the local
and the peripheral activity of the antioxidant systems
only in periodontitis, especially in its chronic form.
Several factors are implicated in the total antioxi-
dant system of serum and plasma regulation. Inter-
pretation of changes in the capability to ROS inactiva-
tion by serum depends on the methodology (no essential
correlation between TAS assessed in different ways).
The conditions of serum storage before assay and the
influence of such factors as diet, physical activity, smok-
ing habit, type of lipid, proteins, and nucleic acid perox-
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Table 3. TAS in serum of venous and gingival blood
Examined  TAS level TAS level
group in venous blood in gingival blood 
(mmol/l) (mmol/l)
All diseased patients  1.75±0.141 1.85±0.16
(n=56)
AgP (n=26) 1.81±0.132 1.89±0.14
CP (n=30)  1.68±0.133, 4 1.81±0.185
Control (n=25) 1.94±0.12 1.94±0.13
1 p=0.000 compared with the control group; 2 p=0.000 com-
pared with the control group; 3 p=0.000 compared with the
control group; 4 p=0.001 significant differences between AgP
and CP; 5 p=0.029 compared with the control group.
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dynamic system. At the first stage of the oxidative burst
in serum or plasma, an adaptive increase in antioxidant
concentration is observed. The subsequent intensifica-
tion of ROS generation leads to the antioxidant protec-
tive system becoming exhausted and an in vivo decrease
in TAS [27]. TAS assessment only provides information
about the current capability of the antioxidant mecha-
nisms depending on the disease phase and cannot be
applied in the assessment of past lesions, not to speak of
future ones.
Significantly decreasing TAS level in the serum of
both of the examined periodontitis patient groups com-
pared with the control group was detected. The lowest
TAS level was observed in the CP group. Sobaniec and
Sobaniec-£otowska [32], in an experimental study in
rats, showed a significant decrease in serum antioxidant
enzyme concentrations (glutathione peroxidase and
superoxide dimutase) 21 days after ligature-induced
periodontitis. Aminoguanidine treatment significantly
reduced ligature-induced periodontitis in rats by reduc-
ing nitric oxide production and oxidative stress [17].
Significantly decreased Trolox-equivalent antioxidant
capacity in serum was detected in children with
Papillon-Lefèvre syndrome and periodontitis [8]. No
differences in the concentrations of antioxidants in
serum between the group with CP and controls were
described by Chapple et al. [13]. Sculley and Langley-
Evans [30] also detected no differences in antioxidant
capacity between patients with periodontitis of different
intensification on the basis of the ferric-reducing ability
of plasma. Discrepancies among the results of the cited
studies arise from the different methodologies, the
absence of homogeneity of the examined groups with
respect to disease intensity, and factors reflecting TAS
in serum or plasma. It should be taken into considera-
tion that a single measurement of TAS limits the obser-
vations of the present study. Prior and Cao [28] indicat-
ed that for an accurate evaluation of the dynamic
changes in antioxidant concentrations in biological sys-
tems, multiple assays are required complementary to
the nature of the assessment method.
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Professor Feliks Milgrom
(1919–2007)
Feliks Milgrom, Professor Emeritus of the University of Buffalo, State University of New York,
died on September 2nd at the age of 88 in the USA.
Professor Milgrom was one of the closest students of Prof. Ludwik Hirszfeld, who was the super-
visor of his doctoral thesis in 1947. Three years later he attained the rank of associate professor.
After Hirszfeld’s death, and on his recommendation, Milgrom became acting director of the
Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, in Wroc³aw
(Poland), and then assumed the post of director of the Department of Microbiology of the
Silesian University School of Medicine in Zabrze (Poland). His scientific potential is best attest-
ed by the fact that he published three papers in Nature during his time there from 1956–1957.
In 1957 he emigrated to the USA and joined the faculty of the Department of Microbiology of
the University of Buffalo School of Medicine and Biomedical Sciences, where he continued his
work in the fields of the immunology of transplantation and the mechanisms of autoimmunity,
becoming chair of the department in 1967 and Distinguished Professor in Microbiology in 1981.
His attachment to his teacher, Prof. Hirszfeld, is underscored by articles to his memory (e.g.
L. Hirszfeld: A posthumous tribute (in Polish), Pol Arch Med Wewn 1956, 11, 1643; Fundamental
discoveries in immunohematology and immunogenetics by Ludwik Hirszfeld, Vox Sang 1987, 52,
149; My relations with five generations of immunologists, Transplant Proc 1999, 31, 1493; My
association with Ludwik Hirszfeld, Wroc³aw 1945–1954, Arch Immunol Ther Exp 1998, 46, 201).
He remained in contact with Poland, and in 1994 he was awarded the Gold Cross of Merit from
the President of the Republic of Poland.
Andrzej Górski
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of the review entitled “Negative signals from FcεRI engagement attenuate mast cell functions” 
published in Arch. Immunol. Ther. Exp., 2007, 55, 219–229 
are expressing their apologies to the authors of the following articles:
Gilfillan A. M. and Tkaczyk C.: “Integrated signalling pathways for mast-cell activation” 
published in Nat. Rev. Immunol., 2006, 6, 218–230;
Rivera J. and Gilfillan A. M.: “Molecular regulation of mast cell activation” 
published in J. Allergy Clin. Immunol., 1996, 117, 1214–1225, 
for not having appropriately cited and acknowledged their work.
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